The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

E.W. Cohen, Ezra; Bryan Bell, R.; Bifulco, Carlo; Burtness, Barbara; L. Gillison, Maura; J. Harrington, Kevin; Le, Quynh‐Thu; Y. Lee, Nancy; S. Leidner, Rom; Lewis, Rebecca; Licitra, Lisa; Mehanna, Hisham; K. Mell, Loren; Raben, Adam; G. Sikora, Andrew; Uppaluri, Ravindra; Whitworth, Fernanda; P. Zandberg, Dan; L. Ferris, Robert

doi:10.1186/s40425-019-0662-5

Public

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Published in Journal for ImmunoTherapy of Cancer • Jul 15, 2019

Authors:

Ezra E.W. Cohen

R. Bryan Bell

Carlo Bifulco

Abstract

Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal sinuses, oropharynx, larynx and nasopharynx represent nearly 700,000 new cases and 380,000 deaths worldwide per annum, and account for over 10,000 annual deaths in the United States alone. Improvement in outco...

Subject

Pembrolizumab

Medicine

Nivolumab

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!